Esperion Therapeutics stock remains a buy as strong drug franchises, growth, and global milestones outweigh risks. Learn more ...
InfuSystem (INFU) is poised for strong growth with rising profits, margin gains, and expansion in patient services. Read here ...
Fresh off hitting a record high, analysts and investors are figuring where -- and how high -- Amazon goes from here. While ...
Palantir (NASDAQ:PLTR) has been the hottest AI stock on Wall Street, right behind Nvidia (NASDAQ:NVDA). The company has been on a beat-and-raise cadence for a long time, and even some of the bearish ...
Vodafone share price popped and reached its highest level since August 2022 as the company’s German business returned to ...
Earlier this week, I went live with InvestorPlace Senior Analysts Louis Navellier, Luke Lango, and Jonathan Rose at our special Profit Surge Event… And at the event, Jonathan unveiled a powerful ...
The average interest rate on a 30-year, fixed-rate mortgage ticked down to 6.12% APR, according to rates provided to NerdWallet by Zillow. This is five basis points lower than yesterday and 16 basis ...
Now, it’s worth noting Stock Advisor's total average return is 1,033% — a market-crushing outperformance compared to 193% for ...
AI is changing the market rapidly. Here are handful of top fourth-quarter recommendations from top strategists.
This exchange-traded fund does what you as an income investor would do so you don't have to, making it a solid long-term ...
Apple Inc. has faced plenty of criticism from Wall Street for not spending as aggressively on artificial intelligence as its Big Tech rivals. But that strategy is suddenly a blessing for the ...
The president's endorsement of Paramount as a buyer for Warner Bros. Discovery signals a new paradigm for M&A in these times.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results